Magnesium ascorbate
CAS 15431-40-0
Magnesium ascorbate (CAS 15431-40-0) is a pharmaceutical compound with 0 bioactivity targets and 238 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Magnesium ascorbate is linked through DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Magnesium ascorbate used for in pharmaceutical contexts?
Magnesium ascorbate (CAS 15431-40-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Magnesium ascorbate?
Magnesium ascorbate has 238 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal pain, Antineutrophil cytoplasmic antibody positive, Anxiety, Arteriosclerosis, Arteriosclerosis coronary artery. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Magnesium ascorbate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Magnesium Ascorbate with EU status "permitted".
What clinical phase is Magnesium ascorbate in?
No phase 1-4 clinical development badge is rendered for Magnesium ascorbate because the matched compound identifier rows do not contain a max-phase value.